These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19909766)

  • 41. Primary hepatocyte culture as an experimental model for the evaluation of interactions between xenobiotics and drug-metabolizing enzymes.
    Li AP; Kedderis GL
    Chem Biol Interact; 1997 Nov; 107(1-2):1-3. PubMed ID: 9402945
    [No Abstract]   [Full Text] [Related]  

  • 42. Can hepatoma cell lines be redifferentiated to be used in drug metabolism studies?
    Martínez-Jiménez CP; Jover R; Gómez-Lechón MJ; Castell JV
    Altern Lab Anim; 2004 Jun; 32 Suppl 1A():65-74. PubMed ID: 23577436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suicide substrates, mechanism-based enzyme inactivators: recent developments.
    Walsh CT
    Annu Rev Biochem; 1984; 53():493-535. PubMed ID: 6433782
    [No Abstract]   [Full Text] [Related]  

  • 44. Quantitative structure-activity relationships for predicting metabolism and modeling cytochrome p450 enzyme activities.
    Long A; Walker JD
    Environ Toxicol Chem; 2003 Aug; 22(8):1894-9. PubMed ID: 12924588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simple but powerful: phenanthroline-based small molecules for cellular imaging and cancer screening.
    Sergeeva NN; Donnier-Marechal M; Vaz GM; Davies AM; Senge MO
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4385-8. PubMed ID: 21733689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of cytochrome P450 in lung tumor.
    Gharavi N; El-Kadi AO
    Curr Drug Metab; 2004 Apr; 5(2):203-10. PubMed ID: 15078197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.
    Imai S; Yoshioka Y; Morishita Y; Yoshida T; Uji M; Nagano K; Mukai Y; Kamada H; Tsunoda S; Higashisaka K; Tsutsumi Y
    Nanoscale Res Lett; 2014; 9(1):651. PubMed ID: 25520598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety.
    Kim JA; Salvati A; Åberg C; Dawson KA
    Nanoscale; 2014 Nov; 6(23):14180-4. PubMed ID: 25340311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of Fe
    Rashtbari S; Hassanpour Aydinlou Z; Sadeghi L
    Bioimpacts; 2024; 14(5):29946. PubMed ID: 39296801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gemcitabine and synthesized silver nanoparticles impact on chemically induced hepatocellular carcinoma in male rats.
    Mohamed MR; Osman SA; Hassan AA; Raafat AI; Refaat MM; Fathy SA
    Int J Immunopathol Pharmacol; 2024; 38():3946320241263352. PubMed ID: 39046434
    [No Abstract]   [Full Text] [Related]  

  • 51. The Impact of Inorganic Systems and Photoactive Metal Compounds on Cytochrome P450 Enzymes and Metabolism: From Induction to Inhibition.
    Havrylyuk D; Heidary DK; Glazer EC
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of Benzo[a]pyrene-Induced Hepatic Lipid Accumulation through CYP1B1-Induced mTOR-Mediated Lipophagy.
    Bu KB; Kim M; Shin MK; Lee SH; Sung JS
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Worker studies suggest unique liver carcinogenicity potential of polyvinyl chloride microplastics.
    Zarus GM; Muianga C; Brenner S; Stallings K; Casillas G; Pohl HR; Mumtaz MM; Gehle K
    Am J Ind Med; 2023 Dec; 66(12):1033-1047. PubMed ID: 37742097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity evaluation of silica nanoparticles for delivery applications.
    Tan Y; Yu D; Feng J; You H; Bai Y; He J; Cao H; Che Q; Guo J; Su Z
    Drug Deliv Transl Res; 2023 Sep; 13(9):2213-2238. PubMed ID: 37024610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sub-Lethal Concentrations of Graphene Oxide Trigger Acute-Phase Response and Impairment of Phase-I Xenobiotic Metabolism in Upcyte
    Romaldini A; Spanò R; Catalano F; Villa F; Poggi A; Sabella S
    Front Bioeng Biotechnol; 2022; 10():867728. PubMed ID: 35662849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of iron oxide nanoparticles on xenobiotic metabolism in HepaRG cells.
    Voss L; Yilmaz K; Burkard L; Vidmar J; Stock V; Hoffmann U; Pötz O; Hammer HS; Peiser M; Braeuning A; Löschner K; Böhmert L; Sieg H
    Arch Toxicol; 2020 Dec; 94(12):4023-4035. PubMed ID: 32914219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoplastics impact the zebrafish (Danio rerio) transcriptome: Associated developmental and neurobehavioral consequences.
    Pedersen AF; Meyer DN; Petriv AV; Soto AL; Shields JN; Akemann C; Baker BB; Tsou WL; Zhang Y; Baker TR
    Environ Pollut; 2020 Nov; 266(Pt 2):115090. PubMed ID: 32693326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome.
    Sekretarska J; Szczepaniak J; Sosnowska M; Grodzik M; Kutwin M; Wierzbicki M; Jaworski S; Bałaban J; Daniluk K; Sawosz E; Chwalibog A; Strojny B
    Materials (Basel); 2019 Dec; 12(24):. PubMed ID: 31835701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of camptothecin-encapsulated poly(lactic-
    Bao H; Zhang Q; Yan Z
    Int J Nanomedicine; 2019; 14():383-391. PubMed ID: 30662262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanostructures of diamond, graphene oxide and graphite inhibit CYP1A2, CYP2D6 and CYP3A4 enzymes and downregulate their genes in liver cells.
    Strojny B; Sawosz E; Grodzik M; Jaworski S; Szczepaniak J; Sosnowska M; Wierzbicki M; Kutwin M; Orlińska S; Chwalibog A
    Int J Nanomedicine; 2018; 13():8561-8575. PubMed ID: 30587978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.